Commitment to focus on and grow SWK's core specialty finance business going forward
– The Company will pursue opportunities to optimize its capital structure with additional leverage to enhance returns and improve the business' growth.
DALLAS, Nov. 1, 2021 /PRNewswire/ — SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an update on the results of the Strategic Review Committee's evaluation of strategic alternatives for the Company.
The Strategic Review Committee was formed by SWK in May 2021 to identify, review and explore strategic alternatives for the Company with a view to maximizing stockholder value. With its advisors, the committee completed a comprehensive review of strategic alternatives for each segment of the Company. The committee did not identify a transaction or alternative strategies that could be supported by both the Company's Board of Directors (the "Board") and Carlson Capital, L.P. ("Carlson"), the Company's principal stockholder.
Following the conclusion of the strategic review, the SWK Board approved a streamlined go-forward business plan and has begun implementing several new measures in light of the Company's current governance. The goal of these measures is to improve SWK's strategic focus, growth profile, and capital allocation. The Board believes these measures will allow the Company to generate long-term value for stockholders.
Winston Black, Chairman and CEO of SWK Holdings, stated, "After conducting a thorough review of alternatives, SWK is excited to announce a number of changes to our corporate strategy. Importantly, our decisions were informed by our own internal valuation of the Company's assets, as well as an independent, third-party valuation that supports our belief that the Company's core specialty finance assets have value in excess of their GAAP carrying value. We believe that, in light of the Company's current governance, growing the specialty finance business while optimizing the Company's capital structure and realizing the value of all of the Company's assets over time is the best way to maximize value for all shareholders."
Mr. Black continued, "SWK has successfully executed investments in small and mid-sized companies in the life sciences sector since 2012. During that time, the team has deployed over $600 million of capital into 42 investments, generating a realized IRR of 20% as of June 30, 2021. We believe that focusing the Company on this successful franchise and positioning it for further success with additional capital and an appropriate amount of leverage should lead to continued growth in cash flow, earnings, and book value, and also improve the Company's return on equity."
Strategy to enhance shareholder return
The SWK Board intends to increase the Company's use of leverage to grow the return on equity and permit the Company to make additional investments. SWK will continue to evaluate strategic alternatives for its non-core assets. SWK will also consider establishing a regular dividend policy and expanding the Company's existing share repurchase program, each subject to approval by Carlson per the 2014 stockholders' agreement, to generate value for stockholders. The Board believes the potential distribution of cash, along with the addition of a prudent leverage structure, could position SWK to realize a greater return on equity and continue to utilize SWK's material Net Operating Loss assets while sticking to its proven core strategy.
Mr. Black concluded, "The combined result of these initiatives should help SWK focus its resources on its core business. Commitment to that strategy and growth in SWK's portfolio should lead to meaningful value creation for shareholders. Further, the Board will continue to look for opportunities for shareholders to participate in the proceeds generated by our specialty finance business. We believe there remains substantial value in our shares when taking into account the core specialty finance business and the additional value represented by our royalties and equity-related/warrant portfolio not reflected in the GAAP carrying value."
About SWK Holdings Corporation
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK's business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "would," "could," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
View original content:https://www.prnewswire.com/news-releases/swk-holdings-announces-strategic-plan-to-focus-on-core-specialty-finance-business-301412647.html
SOURCE SWK Holdings Corporation
Nevada King Gold Corp. (TSX-V: NKG) (OTCQB: VKMTF) ("Nevada King" or the "Company") has engaged a third-party investor relations provider, Gold Standard Media, LLC ("GSM"), to create and develop digital marketing campaigns and other related services to assit the Company in enhancing its online profile with the global investment community.
Meridian Mining UK S (TSXV: MNO) (Frankfurt-Tradegate: 2MM) (OTCQB: MRRDF) ("Meridian" or the "Company") is pleased to provide an update on its "Mine Corridor" soil sampling and mapping programs, at its Cabaçal Copper-Gold project ("Cabaçal") in Mato Grosso, Brazil. Two major untested surface Copper prospects have been confirmed at the C2A target, 3km South-southeast of the Cabaçal mine. Outcropping, fresh-rock mafic units with surface Copper ("Cu") sulphide mineralisation (chalcopyrite) have be
Biotech stocks appear to be poised for a strong showing in November for a host of reasons. Second, the latest earnings reports from top big pharma companies like Merck have been better than expected so far. Lastly, scores of drugmakers are slated to release key clinical and regulatory updates this month.
Shares of GameStop (NYSE: GME) were running 5.6% higher heading into noontime trading Monday despite the announcement the video game retailer's chief operating officer (COO) had quit just seven months after taking the job. The news was dumped on the market late Friday after the stock exchange had closed for the weekend. Companies strive for orderly executive transitions, and though a sudden departure of a chief executive officer or chief financial officer might be more worrisome, the loss of the COO isn't a minor transition.
Inflation is high. You might as well profit from it.
Although investing offers no guarantees, Wall Street has consistently shown that time is investors' greatest ally. The first top stock investors can confidently pile into in November is payment-processing kingpin Visa (NYSE: V). While it doesn't happen often, Visa's quarterly operating results failed to impress Wall Street.
BTIG Securities analyst Gray Powell — a longtime CrowdStrike bull — cut his rating on the growth stock from buy to neutral, noting that his firm's channel checks suggest that competition is becoming more of a threat than it was previously. This could lead growth next year to "downtick from 2021," said Powell in a note to investors. Chief among CrowdStrike's competition, Powell says, is SentinelOne (NYSE: S), which went public this summer.
Today we're going to analyze the Ford Motor Company (NYSE:F). The company's stock saw a significant share price rise of over 20% in the past couple. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price, but an overview of the fundamentals will give investors a better grounding into the future potential of the stock.
In this article, we discuss the 11 best Covid vaccine and pill stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Covid Vaccine and Pill Stocks To Invest In. In late 2020, as the results from trials of COVID-19 vaccines poured in, it […]
Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points. Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint?
Jacqueline Schadeck was 14 years old in 2007 when her life took a dramatic turn. Raised by a single mother in northern California, Schadeck found herself with enough money to buy new clothes and eat in restaurants for the first time. “I finally got my first matching Coach bag and shoes,” Schadeck recalled.
In this article we will take a look at the some of notable stocks trending today. You can skip our detailed analysis of these stocks and go to read Why These 5 Stocks Are Trending on Monday. It’s a relatively quiet day on Wall Street with the Dow Jones up 0.14%, the S&P 500 up […]
Up more than 310,000% Sunday night, “Squid Game” crypto is now valued at under one cent.
It’s not unusual for stocks to exhibit an apparent disconnect between share price and real-world performance, especially since 2021’s rise of the meme stock. While this appears a relatively new trend, you could argue Tesla – for all its increasing real-world success – is the original meme stock. King meme or not, Tesla’s status as the world’s most successful EV company is currently not up for discussion. However, Tesla needs to watch out. Lucid Group (LCID) is currently staking a claim to give i
The 1940s produced compound annual returns of 10.2% annually, including dividends, while the 2010s generated a compound annual growth rate (CAGR) of 14%. For investors who want the best chance of having a comfortable retirement, investing in stocks and staying in the market for the long haul is the correct strategy. Walt Disney (NYSE: DIS), Ubisoft (OTC: UBSFF), and Fiverr International (NYSE: FVRR) are stocks you can buy today if you want to double your money, and you won't have to wait a decade for it to happen.
An encouraging glimpse at last quarter's growth and plans for a brilliant acquisition have stoked investors, though perhaps a bit too much.
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher amid heightened interest in the stock from retail traders on social media. According to SwaggyStocks, Ocugen was the fifth most mentioned stock on Reddit's r/wallstreetbets. Traders also circulated a recent release from the Australian Government mentioning recognition of Bharat Biotech's COVAXIN. NOTE: Ocugen is a partner on COVAXIN. Ocugen's average session volume is 21.45 million over a 100-day period. At publication time, Monday's trading
Roblox Corp. was digging itself out Monday from a three-day outage that shut out millions of users, as investors wiped away more than $1.5 billion of the videogame company's market capitalization.
The Dow Jones rose even as Microsoft and Apple stock fell. Janet Yellen made a new debt demand. Amazon stock took a dive amid a new space move.
The stock markets are at or near record highs right now, buoyed by a strong investors sentiment, especially among retail investors. Stocks represent a strong return while interest rates and bond yields remain low. But for return-minded investors, stocks are not the only game in town. The notoriously volatile Bitcoin has surged 109% this year, peaking above $65,000 earlier this month. Yet, some crypto watchers believe the digital coin will climb even higher. The cryptocurrency sector is worth app
SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business – Yahoo Finance
Commitment to focus on and grow SWK's core specialty finance business going forward